Skip to main content
During the early stages of the H1N1 pandemic, the only vaccine available to hospitals was the live attenuated intranasal (LAIV) version, but many shunned LAIV out of an abundance of concern for high-risk patients.

Hospitals shunned live H1N1 vaccine as pandemic unfolded